Cabozantinib and Nivolumab Among Older Patients With Renal Cell Carcinoma
Cabozantinib and Nivolumab Among Older Patients With Renal Cell Carcinoma
Recruiting · NCT06934057 · Registry updated 2025-09-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Cabozantinib and Nivolumab Among Older Patients With Renal Cell Carcinoma | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, benign urinary system neoplasm, carcinoma, epithelial neoplasm, kidney cancer, kidney disorder, neoplasm, renal cell carcinoma, urinary system disorder | Recruiting | Phase 4 | 2025-09-24 | NCT06934057 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Gustave Roussy, Cancer Campus, Grand Paris | 93 |
| Ipsen | 59 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre Georges François Leclerc | Dijon | France | 42 |
| Centre Léon Bérard | Lyon | France | 77 |
| CHU Tours - Hôpital Bretonneau | Tours | France | 2 |
| Gustave Roussy | Villejuif | France | 48 |
| Hôpital Tenon | Paris | France | 19 |
| Institut de Cancérologie de l'Ouest - Angers | Angers | France | 2 |
| Institut Universitaire Du Cancer Toulouse- Oncopole Claudius Regaud | Toulouse | France | 1 |